{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T07:17:12Z","timestamp":1788333432044,"version":"build-2803163510"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"29","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,17]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Cervical lymph node metastasis (CLNM) plays a crucial role in determining the surgical strategy for patients with papillary thyroid carcinoma (PTC). This study aimed to identify predictive factors for CLNM based on ultrasound features and gene mutation characteristics, and to develop a nomogram model for individualized risk prediction. A total of 171 patients with pathologically confirmed PTC who underwent surgery between January 2023 and October 2025 were retrospectively analyzed. Patients were randomly divided into a training set (n\u2005=\u2005131) and a validation set (n\u2005=\u200540) at a ratio of 7:3. Clinical characteristics, ultrasound imaging features, and thyroid-related gene mutations were collected. Univariate and multivariate logistic regression analyses were performed to identify independent risk factors for CLNM, and a nomogram model was subsequently constructed. Model performance was evaluated using receiver operating characteristic curves, calibration analysis with the Hosmer\u2013Lemeshow test, and decision curve analysis. Significant differences were observed between groups in terms of sex, tumor shape, boundary, calcification, and capsule contact (all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.05). Multivariate logistic regression identified sex (odds ratio [OR]\u2005=\u20052.817), irregular shape (OR\u2005=\u20055.585), obscure boundary (OR\u2005=\u20052.074), calcification (OR\u2005=\u20053.515), and capsule contact (OR\u2005=\u20052.927) as independent predictors of CLNM in PTC (all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.05). A nomogram was constructed based on these variables. The area under the curve was 0.800 (95% CI: 0.723\u20130.876) in the training set and 0.775 (95% CI: 0.628\u20130.922) in the validation set. The model demonstrated good calibration and clinical utility as indicated by the Hosmer\u2013Lemeshow test (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&gt;\u2005.05) and decision curve analysis. A nomogram integrating ultrasound features and clinical factors was developed to predict CLNM in patients with PTC, showing favorable predictive performance and potential clinical utility. Future prospective, multicenter studies with larger sample sizes and more comprehensive datasets are needed to further validate and optimize the model, thereby improving its generalizability and supporting individualized clinical decision-making.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049837","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T21:02:47Z","timestamp":1784322167000},"page":"e49837","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Risk factors for cervical lymph node metastasis in patients with papillary thyroid carcinoma in Anhui Province, China: A retrospective study (2023\u20132025)"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5610-2254","authenticated-orcid":false,"given":"Xiaoxiang","family":"Dong","sequence":"first","affiliation":[{"name":"Department of Ultrasound Medicine, Tianchang Hospital of Traditional Chinese Medicine, Tianchang, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Hu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Digital Technology in Medical Diagnostics of Zhejiang Province, Dian Diagnostics Group Co., Ltd., Hangzhou, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihai","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Ultrasound Medicine, Tianchang Hospital of Traditional Chinese Medicine, Tianchang, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Ultrasound Medicine, Tianchang Hospital of Traditional Chinese Medicine, Tianchang, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260902","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.2967\/jnumed.121.261898","article-title":"Minimal extrathyroid extension in papillary micro carcinoma of the thyroid is an independent risk factor for relapse through lymph node and distant metastases.","volume":"62","author":"Seifert","year":"2021","journal-title":"J Nucl Med"},{"key":"R2-20260902","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3390\/biomedicines12020350","article-title":"Minimal Extrathyroid Extension (mETE) as the only risk factor in patients with Papillary Thyroid Carcinoma (PC): its clinical impact on recurrence and outcome during long-term follow-up.","volume":"12","author":"Marongiu","year":"2024","journal-title":"Biomedicines"},{"key":"R3-20260902","doi-asserted-by":"crossref","first-page":"640565","DOI":"10.3389\/fendo.2021.640565","article-title":"Risk factors for central and lateral lymph node metastases in patients with papillary thyroid micro-carcinoma: retrospective analysis on 484 cases.","volume":"12","author":"Huang","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R4-20260902","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1089\/thy.2021.0679","article-title":"Active surveillance versus immediate surgery for low-risk papillary thyroid microcarcinoma patients in south korea: a cost-minimization analysis from the MAeSTro study.","volume":"32","author":"Kim","year":"2022","journal-title":"Thyroid"},{"key":"R5-20260902","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1089\/thy.2021.0614","article-title":"Progression of low-risk papillary thyroid microcarcinoma during active surveillance: interim analysis of a multicenter prospective cohort study of active surveillance on papillary thyroid microcarcinoma in Korea.","volume":"32","author":"Lee","year":"2022","journal-title":"Thyroid"},{"key":"R6-20260902","doi-asserted-by":"crossref","first-page":"12459","DOI":"10.3390\/ijms241512459","article-title":"BRAF, TERT and HLA-G status in the papillary thyroid carcinoma: a clinicopathological association study.","volume":"24","author":"Bertol","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R7-20260902","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.21873\/anticanres.17128","article-title":"Association of BRAF or TERT promoter mutations and advanced papillary thyroid carcinoma.","volume":"44","author":"Toda","year":"2024","journal-title":"Anticancer Res"},{"key":"R8-20260902","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.1245\/s10434-024-15500-9","article-title":"Defining the genomic landscape of diffuse sclerosing papillary thyroid carcinoma: prognostic implications of RET fusions.","volume":"31","author":"Scholfield","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"R9-20260902","doi-asserted-by":"crossref","first-page":"1611138","DOI":"10.3389\/pore.2023.1611138","article-title":"RET rearrangements are relevant to histopathologic subtypes and clinicopathological features in Thai papillary thyroid carcinoma patients.","volume":"29","author":"Khonrak","year":"2023","journal-title":"Pathol Oncol Res"},{"key":"R10-20260902","doi-asserted-by":"crossref","first-page":"121","DOI":"10.20892\/j.issn.2095-3941.2018.0125","article-title":"Risk factors for cervical lymph node metastasis in papillary thyroid microcarcinoma: a study of 1,587 patients.","volume":"16","author":"Zheng","year":"2019","journal-title":"Cancer Biol Med"},{"key":"R11-20260902","doi-asserted-by":"crossref","first-page":"8579828","DOI":"10.1155\/2019\/8579828","article-title":"Risk factors for cervical lymph node metastasis of papillary thyroid microcarcinoma: a single-center retrospective study.","volume":"2019","author":"Cheng","year":"2019","journal-title":"Int J Endocrinol"},{"key":"R12-20260902","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fendo.2020.00265","article-title":"Risk factors for lymph node metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis.","volume":"11","author":"Mao","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R13-20260902","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer.","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"R14-20260902","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jacr.2017.01.046","article-title":"ACR Thyroid Imaging, Reporting and Data System (TI-RADS): white paper of the ACR TI-RADS committee.","volume":"14","author":"Tessler","year":"2017","journal-title":"J Am Coll Radiol"},{"key":"R15-20260902","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1089\/thy.2017.0500","article-title":"The 2017 bethesda system for reporting thyroid cytopathology.","volume":"27","author":"Cibas","year":"2017","journal-title":"Thyroid"},{"key":"R16-20260902","doi-asserted-by":"crossref","first-page":"214","DOI":"10.32725\/jab.2024.025","article-title":"BRAF V600E positive papillary thyroid carcinoma (TERT and TP53 mutation coexistence excluded): correlation of clinicopathological features and the extent of surgical treatment and its complications.","volume":"22","author":"Hlozek","year":"2024","journal-title":"J Appl Biomed"},{"key":"R17-20260902","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/ct.2022;34.161-164","article-title":"Childhood exposure to excess ionizing radiation is associated with dose-dependent fusions as molecular drivers of papillary thyroid cancer.","volume":"34","author":"Klubo-Gwiezdzinska","year":"2022","journal-title":"Clin Thyroidol"},{"key":"R18-20260902","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s12020-023-03416-5","article-title":"Potential impact of obesity on the aggressiveness of low- to intermediate-risk papillary thyroid carcinoma: results from a MASTER cohort study.","volume":"82","author":"Kim","year":"2023","journal-title":"Endocrine"},{"key":"R19-20260902","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1001\/jamasurg.2022.5781","article-title":"Comparison of lobectomy vs total thyroidectomy for intermediate-risk papillary thyroid carcinoma with lymph node metastasis.","volume":"158","author":"Xu","year":"2023","journal-title":"JAMA Surg"},{"key":"R20-20260902","doi-asserted-by":"crossref","first-page":"1288527","DOI":"10.3389\/fendo.2023.1288527","article-title":"Risk factors for central lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study.","volume":"14","author":"Du","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R21-20260902","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1007\/s00405-023-08156-w","article-title":"Integrating US-guided FNAB, BRAF(V600E) mutation, and clinicopathologic characteristics to predict cervical central lymph-node metastasis in preoperative patients with cN0 papillary thyroid carcinoma.","volume":"280","author":"Ma","year":"2023","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"R22-20260902","doi-asserted-by":"crossref","first-page":"2286337","DOI":"10.1080\/07853890.2023.2286337","article-title":"Central lymph nodes in frozen sections can effectively guide extended lymph node resection for papillary thyroid carcinoma.","volume":"55","author":"Peng","year":"2023","journal-title":"Ann Med"},{"key":"R23-20260902","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/s12020-023-03632-z","article-title":"Clinical prediction models for cervical lymph node metastasis of papillary thyroid carcinoma.","volume":"84","author":"Luo","year":"2024","journal-title":"Endocrine"},{"key":"R24-20260902","doi-asserted-by":"crossref","first-page":"789310","DOI":"10.3389\/fendo.2021.789310","article-title":"Predictors and a prediction model for central cervical lymph node metastasis in Papillary Thyroid Carcinoma (cN0).","volume":"12","author":"Gao","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R25-20260902","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1177\/0145561320967339","article-title":"A retrospective study of lymph node yield in lateral neck dissection for papillary thyroid carcinoma.","volume":"101","author":"Issa","year":"2022","journal-title":"Ear Nose Throat J"},{"key":"R26-20260902","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.asjsur.2022.02.027","article-title":"Delphian lymph node metastasis predicts occult contralateral carcinoma for unilateral papillary thyroid carcinoma patients with contralateral benign nodules.","volume":"46","author":"Chen","year":"2023","journal-title":"Asian J Surg"},{"key":"R27-20260902","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12957-024-03565-5","article-title":"Risk factor analysis and prediction model construction for contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma: sex, extrathyroidal tumor extension (ETE), tumor diameter and ipsilateral central lymph node metastasis (ICLNM) are risk factor for unilateral papillary thyroid carcinoma (UPTC): a case control study.","volume":"22","author":"Qin","year":"2024","journal-title":"World J Surg Oncol"},{"key":"R28-20260902","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jss.2021.11.004","article-title":"Sex differences in papillary thyroid cancer.","volume":"271","author":"Remer","year":"2022","journal-title":"J Surg Res"},{"key":"R29-20260902","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1177\/01945998211009858","article-title":"Dynamic nomogram for predicting lateral cervical lymph node metastasis in papillary thyroid carcinoma.","volume":"166","author":"Zhuo","year":"2022","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R30-20260902","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12880-024-01354-w","article-title":"Application of color doppler ultrasound and US shear wave elastography with connective tissue growth factor in the risk assessment of papillary thyroid carcinoma.","volume":"24","author":"Leng","year":"2024","journal-title":"BMC Med Imaging"},{"key":"R31-20260902","doi-asserted-by":"crossref","first-page":"1336787","DOI":"10.3389\/fendo.2024.1336787","article-title":"Score based on contrast-enhanced ultrasound predict central lymph node metastasis in papillary thyroid cancer.","volume":"15","author":"He","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R32-20260902","first-page":"354","article-title":"Overexpression of BZW1 promotes invasion and metastasis of gastric cancer cells by regulating Wnt\/\u03b2-catenin signaling and promoting epithelial-mesenchymal transition.","volume":"44","author":"Zhang","year":"2024","journal-title":"J South Med Univ"},{"key":"R33-20260902","doi-asserted-by":"crossref","first-page":"1108125","DOI":"10.3389\/fendo.2023.1108125","article-title":"Predictive nomogram for central lymph node metastasis in papillary thyroid microcarcinoma based on pathological and ultrasound features.","volume":"14","author":"Wang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R34-20260902","doi-asserted-by":"crossref","first-page":"1330896","DOI":"10.3389\/fendo.2024.1330896","article-title":"The model for predicting the central lymph node metastasis in cN0 papillary thyroid microcarcinoma with Hashimoto\u2019s thyroiditis.","volume":"15","author":"Lin","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R35-20260902","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1089\/thy.2020.0317","article-title":"Interobserver reproducibility in sonographic measurement of diameter and volume of papillary thyroid microcarcinoma.","volume":"31","author":"Chung","year":"2021","journal-title":"Thyroid"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049837","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T07:01:53Z","timestamp":1788332513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":35,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049837","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"2025-12-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}